UCSF

Topics and Expertise: Alzheimer’s disease

New clues in the hunt for Alzheimer’s therapies

Pharmaceutical chemist Arkin and neurologist Grinberg discover a new protein aggregate in Alzheimer’s disease.

School scientists identify faulty molecular recycling as potential driver of Alzheimer’s disease

School scientists recently uncovered how neurons normally recycle old proteins, and how this process goes awry in Alzheimer's disease, leading to the toxic building of protein fragments in the brain.

School of Pharmacy biotech symposium features case histories of future pharmaceuticals

The 2nd Annual Bay Area Biotechnology Symposium, presented by the UCSF School of Pharmacy’s Industry Outreach Program in coordination with the UCSF Postdoctoral Scholars Association at Mission Bay in late May 2011, fully lived up to its billing: “Pharmaceuticals of the Futur